reported that the dupilumab treatment reduces S. aureus colonization in patients with AD (78), suggesting that basophil-derived IL-4/IL-13 may also promote cutaneous S. aureus infections in AD patients. This evidence concerns the gene IL13 and Alzheimer disease.